You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination

Citation Tools

Article menu
Immunotherapy biomarkers
Original research
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Sun Z, Mai H, Xue C, et al
Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination
Journal for ImmunoTherapy of Cancer 2023;11:e007415. doi: 10.1136/jitc-2023-007415